SCHEMBL29135312

SCHEMBL29135312

COc1cccc(-c2ccc3c(c2)CCN(C(C)c2ccccc2F)C3=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TMEM97 Q5BJF2 3/20 0.41
▸ SIGMAR1 Q99720 3/20 0.41
▸ HTR1A P08908 2/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ SLC6A3 Q01959 2/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ ADRA1D P25100 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ ADRA1B P35368 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ HRH3 Q9Y5N1 3/20 0.41
▸ ROCK2 O75116 2/20 0.41
▸ ROCK1 Q13464 1/20 0.41
▸ TNIK Q9UKE5 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29135310 0.92 SLC11A2 (0.42) DRD4DRD3HRH3ROCK2ROCK1
SCHEMBL29135309 0.89 HRH3 (0.55) HRH3CYP11B1CYP11B2
SCHEMBL29135319 0.85 HRH3 (0.47) HRH3
SCHEMBL29135318 0.84 HRH3 (0.55) HRH3CYP11B1CYP11B2
SCHEMBL29135307 0.84 HRH3 (0.52) DRD3HRH3CYP11B1CYP11B2AKR1C3
SCHEMBL29135306 0.82 HRH3 (0.47) DRD4DRD3HRH3CYP11B2
SCHEMBL29135315 0.81 HRH3 (0.40) HRH3
SCHEMBL29135311 0.81 DRD2 (0.44) DRD4SLC6A3DRD3HRH3SLC6A2
SCHEMBL29135308 0.79 HRH3 (0.43) DRD4DRD3HRH3CYP11B1CYP11B2
SCHEMBL29135320 0.79 HRH3 (0.44) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114989085-B Aryl lactam ring compound, pharmaceutical composition and application thereof 安徽医科大学 2023-11-24 — — CN disclosed
Send feedback